ZA200407913B - Polycyclic compounds as potent alpha2-adrenoceptorantagonists. - Google Patents
Polycyclic compounds as potent alpha2-adrenoceptorantagonists.Info
- Publication number
- ZA200407913B ZA200407913B ZA200407913A ZA200407913A ZA200407913B ZA 200407913 B ZA200407913 B ZA 200407913B ZA 200407913 A ZA200407913 A ZA 200407913A ZA 200407913 A ZA200407913 A ZA 200407913A ZA 200407913 B ZA200407913 B ZA 200407913B
- Authority
- ZA
- South Africa
- Prior art keywords
- adrenoceptorantagonists
- polycyclic compounds
- alpha2
- potent
- potent alpha2
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20020642A FI20020642A0 (fi) | 2002-04-03 | 2002-04-03 | Polysykliset yhdisteet tehokkaina alfa2-adrenoseptoriantagonisteina |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200407913B true ZA200407913B (en) | 2005-10-06 |
Family
ID=8563695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200407913A ZA200407913B (en) | 2002-04-03 | 2004-09-30 | Polycyclic compounds as potent alpha2-adrenoceptorantagonists. |
Country Status (6)
| Country | Link |
|---|---|
| KR (1) | KR20040111473A (uk) |
| FI (1) | FI20020642A0 (uk) |
| NO (1) | NO20044627L (uk) |
| TW (1) | TW200400028A (uk) |
| UA (1) | UA80968C2 (uk) |
| ZA (1) | ZA200407913B (uk) |
-
2002
- 2002-04-03 FI FI20020642A patent/FI20020642A0/fi unknown
-
2003
- 2003-03-04 UA UA20041108959A patent/UA80968C2/uk unknown
- 2003-04-03 TW TW092107597A patent/TW200400028A/zh unknown
- 2003-04-03 KR KR10-2004-7015702A patent/KR20040111473A/ko active Search and Examination
-
2004
- 2004-09-30 ZA ZA200407913A patent/ZA200407913B/xx unknown
- 2004-10-27 NO NO20044627A patent/NO20044627L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20044627L (no) | 2004-10-27 |
| UA80968C2 (en) | 2007-11-26 |
| TW200400028A (en) | 2004-01-01 |
| KR20040111473A (ko) | 2004-12-31 |
| FI20020642A0 (fi) | 2002-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0305918D0 (en) | Novel compounds | |
| GB0304424D0 (en) | Novel compounds | |
| EP1596860A4 (en) | NEW CONNECTIONS | |
| EP1648885A4 (en) | NEW CONNECTIONS | |
| GB0305426D0 (en) | Novel compounds | |
| GB0108133D0 (en) | Substituted polycyclic compounds | |
| GB0304809D0 (en) | Novel compounds | |
| GB0302546D0 (en) | Novel compounds | |
| GB0302431D0 (en) | Novel compounds | |
| ZA200407913B (en) | Polycyclic compounds as potent alpha2-adrenoceptorantagonists. | |
| EP1635834A4 (en) | NEW COMPOUNDS | |
| ZA200407363B (en) | Novel compounds. | |
| GB0305290D0 (en) | Novel compounds | |
| GB0301480D0 (en) | Novel compounds | |
| GB0305564D0 (en) | Novel compounds | |
| GB0305293D0 (en) | Novel compounds | |
| GB0305586D0 (en) | Novel compounds | |
| GB0305292D0 (en) | Novel compounds | |
| GB0305291D0 (en) | Novel compounds | |
| GB0300481D0 (en) | Novel compounds | |
| GB0306209D0 (en) | Novel compounds | |
| GB0318117D0 (en) | Novel compounds | |
| GB0300482D0 (en) | Novel compounds | |
| GB0314627D0 (en) | Novel compounds | |
| GB0305687D0 (en) | Novel compounds |